182 related articles for article (PubMed ID: 28697450)
1. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.
Trebbien R; Fischer TK; Krause TG; Nielsen L; Nielsen XC; Weinreich LS; Lis-Tønder J; Skov MN; Christiansen CB; Emborg HD
J Clin Virol; 2017 Sep; 94():1-7. PubMed ID: 28697450
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.
Flannery B; Zimmerman RK; Gubareva LV; Garten RJ; Chung JR; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Ohmit SE; Belongia EA; McLean HQ; Gaglani M; Piedra PA; Mishin VP; Chesnokov AP; Spencer S; Thaker SN; Barnes JR; Foust A; Sessions W; Xu X; Katz J; Fry AM
J Infect Dis; 2016 Oct; 214(7):1010-9. PubMed ID: 27190176
[TBL] [Abstract][Full Text] [Related]
4. Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.
Flannery B; Kondor RJG; Chung JR; Gaglani M; Reis M; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Kim SS; Blanton L; Kniss K; Budd AP; Brammer L; Stark TJ; Barnes JR; Wentworth DE; Fry AM; Patel M
J Infect Dis; 2020 Jan; 221(1):8-15. PubMed ID: 31665373
[TBL] [Abstract][Full Text] [Related]
5. Ιnfluenza A(H3N2) genetic variants in vaccinated patients in northern Greece.
Melidou A; Gioula G; Exindari M; Ioannou E; Gkolfinopoulou K; Georgakopoulou T; Tsiodras S; Papa A
J Clin Virol; 2017 Sep; 94():29-32. PubMed ID: 28734139
[TBL] [Abstract][Full Text] [Related]
6. Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
Skowronski DM; Chambers C; De Serres G; Dickinson JA; Winter AL; Hickman R; Chan T; Jassem AN; Drews SJ; Charest H; Gubbay JB; Bastien N; Li Y; Krajden M
Euro Surveill; 2018 Feb; 23(5):. PubMed ID: 29409570
[TBL] [Abstract][Full Text] [Related]
7. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Krajden M; Gubbay JB; Drews SJ; Martineau C; Eshaghi A; Kwindt TL; Bastien N; Li Y
Clin Infect Dis; 2016 Jul; 63(1):21-32. PubMed ID: 27025838
[TBL] [Abstract][Full Text] [Related]
8. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
[TBL] [Abstract][Full Text] [Related]
9. Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan.
Sugaya N; Shinjoh M; Kawakami C; Yamaguchi Y; Yoshida M; Baba H; Ishikawa M; Kono M; Sekiguchi S; Kimiya T; Mitamura K; Fujino M; Komiyama O; Yoshida N; Tsunematsu K; Narabayashi A; Nakata Y; Sato A; Taguchi N; Fujita H; Toki M; Myokai M; Ookawara I; Takahashi T
Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784529
[TBL] [Abstract][Full Text] [Related]
10. Interim estimates of divergence date and vaccine strain match of human influenza A(H3N2) virus from systematic influenza surveillance (2010-2015) in Hangzhou, southeast of China.
Li J; Zhou YY; Kou Y; Yu XF; Zheng ZB; Yang XH; Wang HQ
Int J Infect Dis; 2015 Nov; 40():17-24. PubMed ID: 26417878
[TBL] [Abstract][Full Text] [Related]
11. Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18.
Melidou A; Broberg E;
Vaccine; 2017 Sep; 35(37):4828-4835. PubMed ID: 28780977
[TBL] [Abstract][Full Text] [Related]
12. On the lookout for influenza viruses in Italy during the 2021-2022 season: Along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin.
Galli C; Pellegrinelli L; Giardina F; Ferrari G; Uceda Renteria SC; Novazzi F; Masi E; Pagani E; Piccirilli G; Mauro MV; Binda S; Corvaro B; Tiberio C; Lalle E; Maggi F; Russo C; Ranno S; Vian E; Pariani E; Baldanti F; Piralla A;
Virus Res; 2023 Jan; 324():199033. PubMed ID: 36581046
[TBL] [Abstract][Full Text] [Related]
13. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.
Skowronski DM; Janjua NZ; De Serres G; Sabaiduc S; Eshaghi A; Dickinson JA; Fonseca K; Winter AL; Gubbay JB; Krajden M; Petric M; Charest H; Bastien N; Kwindt TL; Mahmud SM; Van Caeseele P; Li Y
PLoS One; 2014; 9(3):e92153. PubMed ID: 24667168
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
[TBL] [Abstract][Full Text] [Related]
15. An epidemic surge of influenza A(H3N2) virus at the end of the 2016-2017 season in Taiwan with an increased viral genetic heterogeneity.
Yang JR; Hsu SZ; Kuo CY; Huang HY; Huang TY; Wang HC; Liu MT
J Clin Virol; 2018; 99-100():15-21. PubMed ID: 29278832
[TBL] [Abstract][Full Text] [Related]
16. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
17. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.
Flannery B; Clippard J; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Petrie JG; McLean HQ; Belongia EA; Gaglani M; Berman L; Foust A; Sessions W; Thaker SN; Spencer S; Fry AM;
MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):10-5. PubMed ID: 25590680
[TBL] [Abstract][Full Text] [Related]
18. Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017.
Hergens MP; Baum U; Brytting M; Ikonen N; Haveri A; Wiman Å; Nohynek H; Örtqvist Å
Euro Surveill; 2017 Feb; 22(8):. PubMed ID: 28251891
[TBL] [Abstract][Full Text] [Related]
19. Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.
Tewawong N; Suntronwong N; Vichiwattana P; Vongpunsawad S; Theamboonlers A; Poovorawan Y
Virus Genes; 2016 Oct; 52(5):711-5. PubMed ID: 27146171
[TBL] [Abstract][Full Text] [Related]
20. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13--a rapid epidemiological and virological assessment.
Bragstad K; Emborg H; Fischer TK; Voldstedlund M; Gubbels S; Andersen B; Molbak K; Krause T
Euro Surveill; 2013 Feb; 18(6):. PubMed ID: 23410258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
